Vascular Surgery Service, Heart and Vessels Department, Hospital Santa Maria (CHULN), Lisbon, Portugal; Lisbon Academic Medical Centre, Lisbon, Portugal.
Vascular Surgery Service, Heart and Vessels Department, Hospital Santa Maria (CHULN), Lisbon, Portugal; Lisbon Academic Medical Centre, Lisbon, Portugal; Faculty of Medicine, University of Lisbon, Lisbon, Portugal.
J Vasc Surg. 2020 Sep;72(3):813-821. doi: 10.1016/j.jvs.2019.11.033. Epub 2020 Feb 14.
Aortic arch aneurysmal disease remains a therapeutic challenge. For patients unsuitable for standard open surgery, hybrid repair with debranching of the supra-aortic arteries followed by thoracic endovascular grafting has been shown to be an effective solution. The aim of this study was to report the clinical outcomes of a single-institution experience using hybrid aortic arch repair.
The cases of all consecutive patients submitted to hybrid aortic arch repair between January 2010 and June 2018 were prospectively collected and retrospectively analyzed. The outcomes of the study were 30-day mortality, perioperative complications, 2-year survival, endoleak, and reintervention rates.
A total of 35 patients with a median age of 71 years (interquartile range, 62-77 years) were submitted to hybrid aortic arch repair, with a median follow-up of 26.9 months (interquartile range, 2.4-63.6 months). Ten procedures (28.6%) were performed urgently for contained rupture. The most common etiology was degenerative (n = 14 [40.0%]). The proximal landing zones according to the Ishimaru classification were zone 2 in 20 patients (57.1%), zone 1 in 12 patients (34.3%), and zone 0 in 3 patients (8.6%). Early endoleaks were observed in six patients (17.1%), equally distributed between type I and type II. Late endoleaks were identified in 4 of 24 patients (16.7%; type I, n = 2 [8.3%]; type II, n = 1 [4.2%]; and type III, n = 1 [4.2%]). Thirty-day mortality rate was 14.3% (n = 5) with an early death rate of 8.7% (2/23) in elective cases and 30.0% (3/10) in urgent cases (odds ratio [OR], 4.93; confidence interval [CI], 0.68-35.67; P = .128). Except in one patient, 30-day mortality was associated with landing zone 0 or zone 1 (26.7% vs 5.0%; OR, 6.91; CI, 0.68-69.86; P = .141). Three patients (8.6%) suffered a postoperative stroke, and no episodes of spinal cord ischemia were observed. Two-year survival rate was 67.8% (CI, 49.4%-80.8%). Survival rates were significantly lower with increasing age (hazard ratio [HR], 1.10; CI, 1.03-1.18; P = .004), urgent procedure (HR, 4.80; CI, 1.56-14.80; P = .003), zone 0 or zone 1 (HR, 6.34; CI, 1.73-23.18; P = .001), presence of arrhythmia (HR, 3.76; CI, 1.22-11.62; P = .013), and cerebrovascular disease (HR, 4.12; CI, 1.38-12.35; P = .006). A multivariate analysis identified age (HR, 1.11; P = .047) and zone 0 or zone 1 (HR, 4.93; P = .033) as the only predictors for overall mortality.
Hybrid aortic arch repair seems to be an alternative for higher risk patients not suitable for open repair, but selection of patients is crucial and may benefit from further refinement. In this study, worse outcomes were seen in older patients and those who required more proximal landing zones.
主动脉弓动脉瘤疾病仍然是一个治疗挑战。对于不适合标准开放手术的患者,在进行主动脉弓分支去分支术(debranching of the supra-aortic arteries)后进行胸主动脉腔内修复术(thoracic endovascular grafting)已被证明是一种有效的解决方案。本研究旨在报告使用杂交主动脉弓修复的单中心经验的临床结果。
前瞻性收集并回顾性分析了 2010 年 1 月至 2018 年 6 月期间连续接受杂交主动脉弓修复的所有患者的病例。该研究的结果是 30 天死亡率、围手术期并发症、2 年生存率、内漏和再介入率。
共 35 例中位年龄 71 岁(四分位距 62-77 岁)的患者接受了杂交主动脉弓修复,中位随访时间为 26.9 个月(四分位距 2.4-63.6 个月)。10 例(28.6%)为包裹性破裂而紧急进行。最常见的病因是退行性病变(n=14 [40.0%])。根据 Ishimaru 分类,近端着陆区在 20 例患者中为 2 区(57.1%),在 12 例患者中为 1 区(34.3%),在 3 例患者中为 0 区(8.6%)。6 例(17.1%)患者出现早期内漏,均为 I 型和 II 型内漏。24 例患者中有 4 例(16.7%)出现迟发性内漏(I 型 2 例 [8.3%];II 型 1 例 [4.2%];III 型 1 例 [4.2%])。30 天死亡率为 14.3%(n=5),择期手术的早期死亡率为 8.7%(2/23),急诊手术的死亡率为 30.0%(3/10)(优势比[OR],4.93;置信区间[CI],0.68-35.67;P=.128)。除 1 例患者外,30 天死亡率与着陆区 0 区或 1 区有关(26.7%比 5.0%;OR,6.91;CI,0.68-69.86;P=.141)。3 例(8.6%)患者发生术后卒中,无脊髓缺血事件发生。2 年生存率为 67.8%(CI,49.4%-80.8%)。随着年龄的增加(危险比[HR],1.10;CI,1.03-1.18;P=.004)、紧急手术(HR,4.80;CI,1.56-14.80;P=.003)、0 区或 1 区(HR,6.34;CI,1.73-23.18;P=.001)、心律失常(HR,3.76;CI,1.22-11.62;P=.013)和脑血管疾病(HR,4.12;CI,1.38-12.35;P=.006),生存率显著降低。多变量分析确定年龄(HR,1.11;P=.047)和 0 区或 1 区(HR,4.93;P=.033)是总死亡率的唯一预测因素。
杂交主动脉弓修复似乎是不适合开放修复的高危患者的替代方法,但患者的选择至关重要,可能需要进一步细化。在这项研究中,年龄较大的患者和需要更近端着陆区的患者预后较差。